Resistance to CYP17 and AR inhibitors such as the AR-7 Splice Variant in prostate cancer

Resistance to CYP17 and AR inhibitors such as the AR-7 Splice Variant in prostate cancer

800 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. David Michael Nanus, M.D. of Weill Cornell Medicine discusses resistance to CYP17 and AR inhibitors such as the AR-7 Splice Variant in prostate cancer at ASCO GU 2016 in San Francisco.
Up Next Autoplay
User Photo